Drug-induced interstitial lung disease: a narrative review of a clinical conundrum
Expert Rev Respir Med. 2024 Jan-Feb;18(1-2):23-39. doi: 10.1080/17476348.2024.2329612. Epub 2024 Mar 19.ABSTRACTINTRODUCTION: Drug-induced interstitial lung disease (DI-ILD) is increasing in incidence, due to the use of many new drugs across a broad range of cancers and chronic inflammatory diseases. The presentation and onset of DI-ILD are variable even for the same drug across different individuals. Clinical suspicion is essential for identifying these conditions, with timely drug cessation an important determinant of outcomes.AREAS COVERED: This review provides a comprehensive and up-to-date summary of epidemiology, ris...
Source: Expert Review of Respiratory Medicine - March 19, 2024 Category: Respiratory Medicine Authors: Megan Harrison Grace Kavanagh Tamera J Corte Lauren K Troy Source Type: research

Drug-induced interstitial lung disease: a narrative review of a clinical conundrum
Expert Rev Respir Med. 2024 Mar 19:1-17. doi: 10.1080/17476348.2024.2329612. Online ahead of print.ABSTRACTINTRODUCTION: Drug-induced interstitial lung disease (DI-ILD) is increasing in incidence, due to the use of many new drugs across a broad range of cancers and chronic inflammatory diseases. The presentation and onset of DI-ILD are variable even for the same drug across different individuals. Clinical suspicion is essential for identifying these conditions, with timely drug cessation an important determinant of outcomes.AREAS COVERED: This review provides a comprehensive and up-to-date summary of epidemiology, risk fac...
Source: Expert Review of Respiratory Medicine - March 19, 2024 Category: Respiratory Medicine Authors: Megan Harrison Grace Kavanagh Tamera J Corte Lauren K Troy Source Type: research